There is a newer version of this record available.

Dataset Open Access

Cloning and test expression of HTT fragment clones - 2019/02/28

Harding, Rachel; Hutchinson, Ashley; Seitova, Alma; Arrowsmith, Cheryl; Lee, Matt


Citation Style Language JSON Export

{
  "publisher": "Zenodo", 
  "DOI": "10.5281/zenodo.2600051", 
  "title": "Cloning and test expression of HTT fragment clones - 2019/02/28", 
  "issued": {
    "date-parts": [
      [
        2019, 
        2, 
        28
      ]
    ]
  }, 
  "abstract": "<p><strong>Project:&nbsp;</strong>High resolution structural analysis of purified HTT proteins</p>\n\n<p><strong>Experiment:&nbsp;</strong>Cloning and test expression of HTT fragment clones</p>\n\n<p><strong>Date completed:&shy;&nbsp;</strong>2019/02/28</p>\n\n<p><strong>Rationale:&nbsp;</strong>I aim to complement our previous work on purifying stable regions of huntingtin by cloning further regions of huntingtin corresponding to discrete HEAT repeats for eukaryotic expression. Constructs will initially be screened by BVES in insect sf9 cells. High quality constructs will undergo extensive crystallization experiments and structure determination by X-ray crystallography using well established high-throughput and systematic protocols in place at the SGC. Any solved structures may allow generation of a pseudoatomic resolution (&lt;4 &Aring;) model of the HTT protein using the cryoEM model as a guide.&nbsp;</p>", 
  "author": [
    {
      "family": "Harding, Rachel"
    }, 
    {
      "family": "Hutchinson, Ashley"
    }, 
    {
      "family": "Seitova, Alma"
    }, 
    {
      "family": "Arrowsmith, Cheryl"
    }, 
    {
      "family": "Lee, Matt"
    }
  ], 
  "note": "Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, S\u00e3o Paulo Research Foundation-FAPESP, Takeda, and Wellcome.", 
  "type": "dataset", 
  "id": "2600051"
}
244
166
views
downloads
All versions This version
Views 244142
Downloads 16681
Data volume 149.3 MB81.5 MB
Unique views 191119
Unique downloads 8252

Share

Cite as